SCLC with higher pretreatment PRSS8 expression, as determined by immunohistochemical (IHC) (n = 34), was also associated with worse OS (P = 0.02) and EFS (P = 0.01) (Fig. 3f, g). This evidence concerns the gene PRSS8 and small cell lung carcinoma.